“Analysis of Azithromycin adverse events in COVID-19 Patients reported to Iraqi Pharmacovigilance center in 2020”, AJPS, vol. 22, no. 3, pp. 35–42, Oct. 2022, doi: 10.32947/ajps.v22i3.887.